Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

PaperCitations, authors & open-access status

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 122 citations, 2017 year and closed oa status.

122
Citations
2017
Year
closed
OA Status

Related on ScholarIQ

Mathias K. Fehr
Author
The Lancet Oncology
Journal
Breast Cancer Treatment Studies
Topic
Breast Cancer Treatment Studies
Topic
Estrogen and related hormone effects
Topic
Advanced Breast Cancer Therapies
Topic
470M+ articles · free account